Table 4.

Cytotoxic effects of fermented chamomile extract (12.7 mg solid/ml) on various cancer cell lines

Culture time (h)	Cytotoxic activity (%)
	AGS		HeLa		LoVo		MCF-7		MRC-5
	NFC	FCLP	NFC	FCLP	NFC	FCLP	NFC	FCLP	NFC	FCLP
0	62.92±0.43	62.31±1.60	76.28±0.47	78.12±2.44	72.30±8.77	74.53±7.13	62.50±2.97	62.92±1.27	70.96±5.08	72.33±2.08
12		74.13±0.33		78.93±3.26		80.67±2.93		78.26±1.99		71.36±1.06
24		80.72±0.45		83.04±0.29		80.40±1.15		78.39±0.97		73.12±3.02
48		82.72±0.16		82.77±0.43		81.13±0.84		79.41±0.24		72.24±2.01
72		95.75±0.36		95.87±0.19		95.01±1.06		91.99±0.64		84.50±2.19
PC		92.75±0.63		91.78±0.27		93.01±2.05		93.01±0.46		86.42±1.91

NFC: nonfermented chamomile; FCLP: fermented chamomile by L. plantarum KCCM 11613P; PC: positive control (1.2 mg/L doxorubicin). Data are represented as mean±standard deviation (SD) in triplicate